Infection Drugs Industry News & Blogs

Industry News & Blogs

ResearchMoz: Vaccine Production Market (Trends, Techniques, Key Players, Spending Estimates and
www.sys-con.com | Feb 16, 2012
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.

Antibiotics No Help Against Most Sinus Infections
www.biospace.com | Feb 15, 2012
Antibiotics don't help fight most sinus infections, although doctors routinely prescribe them for that purpose, according to a U.S. study. Researchers

Optimer Pharma: 2 Potentially Potent Drugs In The Pipeline - Seeking Alpha
seekingalpha.com | Feb 14, 2012
< strong > By < a href='http://seekingalpha.com/author/Scott-Matusow' > Scott Matusow < /a > : < /strong > < p > The following stock was mentioned on Jim Cramer's last Mad Money show on CNBC by a caller recommending it. Let's see if the company has what it takes to be a long-term winner; < /p > < p

Herpes Cold Sore Product Xerclear® Launching for OTC Use in Europe | PRLog
www.prlog.org | Feb 12, 2012
Herpes Cold Sore Product Xerclear® Launching for OTC Use in Europe. The CBCD just learned that Medivir AB has announced that its cold sore product Xerclear®, is being launched for over-the-counter use by its partner GlaxoSmithKline in Europe. - PR11796726

Call to scrap "misleading" GP antibiotic measures | 6minutes
www.6minutes.com.au | Feb 9, 2012
One of the government’s key performance indicators for GPs – the prescribing of antibiotics for common colds – is highly misleading and should be scrapped, epidemiologists say.

HHS and Novartis Dedicate First Cell-Based Flu Vaccine Plant in US - Pharmaceutical Technology
pharmtech.findpharma.com | Jan 6, 2012
Last week, the US Department of Health and Human Services and Novartis Vaccines and Diagnostics dedicated a manufacturing plant that can create influenza vaccine using cultured animal cells instead of the conventional expression system of fertilized eggs.

Approaches for Flexible Manufacturing Facilities in Vaccine Production - With careful analysis to
biopharminternational.findpharma.com | Jan 6, 2012
With careful analysis to mitigate risk, disposable technology and process closure can enable adaptable designs and reduced costs.

Promising results in mice on needle-free candidate universal vaccine against various flu viruses
www.sciencedaily.com | Dec 22, 2011
Scientists have discovered that an antigen common to most influenza viruses, and commonly referred to as matrix protein 2, when administered under the tongue could protect mice against experimental infection caused by various influenza viruses, including the highly pathogenic avian H5 virus and the

amednews: Physicians are paid less to give combination vaccines :: Dec. 21, 2011 ... American
www.ama-assn.org | Dec 21, 2011
Researchers say administering a single injection takes as much time as separate ones because patients need to be counseled about the immunizations.

Newsvine - China prepares for big entry into vaccine market
www.newsvine.com | Nov 29, 2011
The world should get ready for a new Made in China product — vaccines.